Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Haptoglobin genotype and diabetic microangiopathies in Japanese diabetic patients.

Literature DB >> 12187922

Haptoglobin genotype and diabetic microangiopathies in Japanese diabetic patients.

Y Koda, M Soejima, S Yamagishi, S Amano, T Okamoto, Y Inagaki, K Yamada, H Kimura.

Abstract

Entities: Disease Gene Species

Mesh：

Substances：
DNA Primers
Haptoglobins

Year: 2002 PMID： 12187922 DOI： 10.1007/s00125-002-0834-5

Source DB: PubMed Journal: Diabetologia ISSN： 0012-186X Impact factor: 10.122

× No keyword cloud information.

8 in total

1. Comment to: F. M. Nackhoul et al. (2001) Haptoglobin phenotype and diabetic nephropathy. Diabetologia 44: 602-604.

Authors: D J Schaer
Journal: Diabetologia Date: 2001-11 Impact factor: 10.122

2. Haptoglobin genotype as a risk factor for diabetic retinopathy.

Authors: F M Nakhoul; S Marsh; I Hochberg; R Leibu; B P Miller; A P Levy
Journal: JAMA Date: 2000-09-13 Impact factor: 56.272

3. The haptoglobin-gene deletion responsible for anhaptoglobinemia.

Authors: Y Koda; M Soejima; N Yoshioka; H Kimura
Journal: Am J Hum Genet Date: 1998-02 Impact factor: 11.025

4. Duplication within the haptoglobin Hp2 gene.

Authors: N Maeda; F Yang; D R Barnett; B H Bowman; O Smithies
Journal: Nature Date: 1984 May 10-16 Impact factor: 49.962

5. Simple PCR detection of haptoglobin gene deletion in anhaptoglobinemic patients with antihaptoglobin antibody that causes anaphylactic transfusion reactions.

Authors: Y Koda; Y Watanabe; M Soejima; E Shimada; M Nishimura; K Morishita; S Moriya; S Mitsunaga; K Tadokoro; H Kimura
Journal: Blood Date: 2000-02-15 Impact factor: 22.113

6. Haptoglobin phenotype and diabetic nephropathy.

Authors: F M Nakhoul; R Zoabi; Y Kanter; M Zoabi; K Skorecki; I Hochberg; R Leibu; B Miller; A P Levy
Journal: Diabetologia Date: 2001-05 Impact factor: 10.122

7. Association of an (A-C)n dinucleotide repeat polymorphic marker at the 5'-region of the aldose reductase gene with retinopathy but not with nephropathy or neuropathy in Japanese patients with Type 2 diabetes mellitus.

Authors: F Ichikawa; K Yamada; S Ishiyama-Shigemoto; X Yuan; K Nonaka
Journal: Diabet Med Date: 1999-09 Impact factor: 4.359

Review 8. Biological and clinical significance of haptoglobin polymorphism in humans.

Authors: M R Langlois; J R Delanghe
Journal: Clin Chem Date: 1996-10 Impact factor: 8.327

8 in total

5 in total

Haptoglobin genotype and diabetic microangiopathies in Japanese diabetic patients.

1. Comment to: F. M. Nackhoul et al. (2001) Haptoglobin phenotype and diabetic nephropathy. Diabetologia 44: 602-604.

2. Haptoglobin genotype as a risk factor for diabetic retinopathy.

3. The haptoglobin-gene deletion responsible for anhaptoglobinemia.

4. Duplication within the haptoglobin Hp2 gene.

5. Simple PCR detection of haptoglobin gene deletion in anhaptoglobinemic patients with antihaptoglobin antibody that causes anaphylactic transfusion reactions.

6. Haptoglobin phenotype and diabetic nephropathy.

7. Association of an (A-C)n dinucleotide repeat polymorphic marker at the 5'-region of the aldose reductase gene with retinopathy but not with nephropathy or neuropathy in Japanese patients with Type 2 diabetes mellitus.

Review 8. Biological and clinical significance of haptoglobin polymorphism in humans.

1. Haptoglobin2-2 phenotype is an additional risk factor of retinopathy in type 2 diabetes mellitus.

2. Haptoglobin polymorphism in individuals with type 2 diabetic microangiopathy.

3. Genetic markers for urine haptoglobin is associated with decline in renal function in type 2 diabetes in East Asians.

4. Haptoglobin genotype and renal function decline in type 1 diabetes.

5. Inflammatory markers and haptoglobin polymorphism in Saudi with non-insulin-dependent diabetes mellitus.